This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here is What to Know Beyond Why Procter & Gamble Company (The) (PG) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching P&G (PG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Solid Economic Data Unnerve Investors: 5 Low-Beta Picks
by Nalak Das
We have narrowed our search to five consumer staples stocks with low-beta and a solid dividend yield. These are: CAG, PG, PM, KO and MDLZ.
Like Income? 3 Consumer Staples Stocks Worth a Look
by Derek Lewis
Many Consumer Staples stocks pay dividends, providing a passive income stream and a cushion against the impacts of drawdowns. And these three stocks are no different, all currently yielding more than 2.5% annually.
The Zacks Analyst Blog Highlights The Coca-Cola, Caterpillar, salesforce.com, The Procter & Gamble and Visa
by Zacks Equity Research
The Coca-Cola, Caterpillar, salesforce.com, The Procter & Gamble and Visa are part of the Zacks top Analyst Blog.
5 Blue-Chip Stocks to Buy Despite Dow's Sluggish Start in 2023
by Nalak Das
We have narrowed our search to five blue-Chip (components of Dow) stocks with strong potential for 2023. These are: PG, V, CRM, CAT and KO.
Down -8.52% in 4 Weeks, Here's Why P&G (PG) Looks Ripe for a Turnaround
by Zacks Equity Research
P&G (PG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Wall Street Bulls Look Optimistic About P&G (PG): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Clorox (CLX) Q2 Earnings and Sales Beat, Stock Rises 4.2%
by Zacks Equity Research
Clorox's (CLX) Q2 results reflect gains from strong demand trends, improved pricing, cost savings and strong execution, offset by lower volume and higher commodity costs.
The Zacks Analyst Blog Highlights Visa, Procter & Gamble, Infosys, Block and Devon Energy
by Zacks Equity Research
Visa, Procter & Gamble, Infosys, Block and Devon Energy are included in this Analyst Blog.
Top Analyst Reports for Visa, Procter & Gamble & Infosys
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), The Procter & Gamble Company (PG) and Infosys Limited (INFY).
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
P&G (PG) Loses -7.88% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
P&G (PG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Wall Street Analysts Think P&G (PG) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Procter & Gamble Company The (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
P&G (PG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Beat the Market Like Zacks: Boeing, Starbucks, Syndax Pharma in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Making Sense of the Early Q4 Results: Is An Earnings Cliff Coming?
by Sheraz Mian
By the end of this week, we will have seen quarterly results from about 28% of all S&P 500 members and will have a very good sense of whether the earnings-cliff narrative has started unfolding or been further pushed out.
Company News for Jan 20, 2023
by Zacks Equity Research
Companies in The News Are: PG, DVN, TFC, NVDA
Soft Housing Sector Data for December
by Zacks Equity Research
Soft Housing Sector Data for December.
Sell-Off Continues as Jobless Claims, Housing Starts Improve
by Mark Vickery
Pre-market futures are trading down in continuation of yesterday's sell-off: the Dow -300 points, the S&P 500 -35 and the Nasdaq -110 points at this hour.
Procter & Gamble (PG) Beats Q2 Earnings & Sales Estimates
by Zacks Equity Research
Procter & Gamble (PG) Q2 results reflect gains from robust pricing and a favorable mix, mostly offset by elevated commodity and input costs, and currency headwinds.
The Zacks Analyst Blog Highlights The Procter & Gamble, Corteva, e.l.f. Beauty, Mondelez International and TreeHouse Foods
by Zacks Equity Research
The Procter & Gamble, Corteva, e.l.f. Beauty, Mondelez International and TreeHouse Foods are part of the Zacks top Analyst Blog.
Procter & Gamble (PG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 0.63% and 0.81%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Time to Buy These Consumer Staples Stocks Before Earnings?
by Shaun Pruitt
As we progress through earnings season, investors may want to pay attention to the Consumer Staples sector as there are quite a few stocks that could beat earnings expectations.
OPEX Looms: 3 Reasons Markets May Need to Digest
by Andrew Rocco
Markets have been on a tear the past three weeks as inflation fears among investors have dissipated. Today, Andrew Rocco discusses why the market is showing some subtle signs that it may need to take a breather in the short term.